CIPLA
Back to All Ratios
|
CIPLA Last 5 Year Pre Tax Margin History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Pre Tax Margin(%) | 16.10 | 13.05 | 11.75 | 11.66 | 8.03 |
What is the latest Pre Tax Margin ratio of CIPLA ?
Year | Pre Tax Margin |
---|---|
Mar2024 | 16.10 |
Mar2023 | 13.05 |
Mar2022 | 11.75 |
Mar2021 | 11.66 |
Mar2020 | 8.03 |
How is Pre Tax Margin of CIPLA Trending?
Years | Pre Tax Margin | % Change | |
---|---|---|---|
Mar2024 | 16.1 | 23.37 | |
Mar2023 | 13.05 | 11.06 | |
Mar2022 | 11.75 | 0.77 | |
Mar2021 | 11.66 | 45.21 | |
Mar2020 | 8.03 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Pre Tax Margin ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹120,857.3 Cr | 7% | 2.4% | 0.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,123.0 Cr | 2.2% | 3% | 5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,844.0 Cr | 8.9% | 3.4% | 47.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,020.0 Cr | -0.2% | 5.4% | 21.3% | Stock Analytics | |
MANKIND PHARMA | ₹104,071.0 Cr | 2.1% | 9.8% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,755.1 Cr | 6.2% | 3.5% | -10.1% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 7% |
2.4% |
0.9% |
SENSEX | 5.3% |
4% |
3.2% |
You may also like the below Video Courses